Global Rosuvastatin Calcium Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Rosuvastatin Calcium market size will reach 647.58 Million USD in 2025 and is projected to reach 847.59 Million USD by 2032, with a CAGR of 3.92% (2025-2032). Notably, the China Rosuvastatin Calcium market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Rosuvastatin calcium is a medication belonging to the statin class used to lower cholesterol levels in the blood. It works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis in the liver. By blocking this enzyme, rosuvastatin reduces the production of cholesterol and increases the liver's ability to remove LDL cholesterol from the bloodstream. It is primarily prescribed to treat conditions such as hypercholesterolemia and mixed dyslipidemia, as well as to prevent cardiovascular events such as heart attacks and strokes in individuals at high risk. Rosuvastatin is typically taken orally in tablet form and is often combined with lifestyle modifications such as dietary changes and exercise to optimize its effectiveness in managing cholesterol levels and reducing cardiovascular risk. Common brand names for rosuvastatin calcium include Crestor and Rosulip.

The major global  manufacturers of Rosuvastatin Calcium include AstraZeneca, Teva Pharmaceutical Industries, MSN Laboratories, Cadila Pharmaceuticals, LGM Pharma, Bal Pharma, Changzhou Pharmaceutical Factory, Jingxin Pharm, HEC Pharm, Zhejiang Hisun Pharmaceutical, Lunan Pharmaceutical, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Shandong Bechem Chemicals, CTX Life Sciences, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Rosuvastatin Calcium. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Rosuvastatin Calcium market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Rosuvastatin Calcium market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Rosuvastatin Calcium industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Rosuvastatin Calcium Include:

AstraZeneca

Teva Pharmaceutical Industries

MSN Laboratories

Cadila Pharmaceuticals

LGM Pharma

Bal Pharma

Changzhou Pharmaceutical Factory

Jingxin Pharm

HEC Pharm

Zhejiang Hisun Pharmaceutical

Lunan Pharmaceutical

Nanjing Frochem Tech

Lianyungang Runzhong Pharmaceutical

Shandong Bechem Chemicals

CTX Life Sciences

Rosuvastatin Calcium Product Segment Include:

Purity 98.0%

Purity 99.0%

Others

Rosuvastatin Calcium Product Application Include:

Tablet

Capsule

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Rosuvastatin Calcium Industry PESTEL Analysis

Chapter 3: Global Rosuvastatin Calcium Industry Porter's Five Forces Analysis

Chapter 4: Global Rosuvastatin Calcium Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Rosuvastatin Calcium Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Rosuvastatin Calcium Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Rosuvastatin Calcium Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources